23andMe Holding Co. (NASDAQ:ME) Short Interest Update

23andMe Holding Co. (NASDAQ:ME) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 1,700,000 shares, a growth of 22.3% from the February 13th total of 1,390,000 shares. Approximately 10.7% of the company’s stock are short sold. Based on an average daily volume of 299,500 shares, the short-interest ratio is presently 5.7 days.

Institutional Trading of 23andMe

Several hedge funds have recently made changes to their positions in ME. Shay Capital LLC lifted its holdings in shares of 23andMe by 71.7% in the 4th quarter. Shay Capital LLC now owns 702,530 shares of the company’s stock worth $2,283,000 after purchasing an additional 293,358 shares during the last quarter. FMR LLC lifted its holdings in shares of 23andMe by 24.0% in the 3rd quarter. FMR LLC now owns 993,848 shares of the company’s stock worth $345,000 after purchasing an additional 192,099 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of 23andMe by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 4,246,093 shares of the company’s stock worth $1,476,000 after purchasing an additional 28,252 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of 23andMe in the 4th quarter worth approximately $49,000. Finally, MassMutual Private Wealth & Trust FSB bought a new stake in shares of 23andMe in the 4th quarter worth approximately $40,000. Institutional investors own 36.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 23andMe in a report on Friday, March 7th.

23andMe Stock Down 4.5 %

NASDAQ:ME traded down $0.09 during trading hours on Tuesday, reaching $1.91. 75,146 shares of the stock were exchanged, compared to its average volume of 266,530. The firm has a 50 day simple moving average of $2.68 and a 200-day simple moving average of $4.02. 23andMe has a 52 week low of $1.34 and a 52 week high of $12.76. The stock has a market capitalization of $51.24 million, a P/E ratio of -0.12 and a beta of 1.19.

23andMe (NASDAQ:ME) last released its earnings results on Tuesday, January 28th. The company reported ($1.02) EPS for the quarter. 23andMe had a negative return on equity of 170.07% and a negative net margin of 183.39%.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.